Financials Guangdong Lifestrong Pharmacy Co., Ltd.

Equities

301111

CNE1000054T7

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-06-17 pm EDT 5-day change 1st Jan Change
14.69 CNY +0.89% Intraday chart for Guangdong Lifestrong Pharmacy Co., Ltd. +2.16% -40.19%

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 7,720 3,139 3,930
Enterprise Value (EV) 1 7,167 2,688 3,598
P/E ratio 101 x 93.4 x 117 x
Yield 0.33% 0.51% 0.41%
Capitalization / Revenue 22.1 x 11.1 x 13.4 x
EV / Revenue 20.5 x 9.49 x 12.3 x
EV / EBITDA 96.2 x 82.5 x 103 x
EV / FCF 118 x 49.5 x -63.8 x
FCF Yield 0.85% 2.02% -1.57%
Price to Book 10.3 x 4.14 x 5.06 x
Nbr of stocks (in thousands) 160,000 160,000 160,000
Reference price 2 48.25 19.62 24.56
Announcement Date 4/24/22 4/27/23 4/22/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 290.5 316.6 341 349.8 283.3 292.4
EBITDA 1 81.37 82.9 75.72 74.47 32.57 34.9
EBIT 1 73.32 74.11 64.33 60.51 21.45 24.46
Operating Margin 25.24% 23.41% 18.87% 17.3% 7.57% 8.37%
Earnings before Tax (EBT) 1 74.38 80.18 72.46 66.72 34.75 37.29
Net income 1 63.6 66.63 62.52 57.18 33.42 33.5
Net margin 21.89% 21.05% 18.34% 16.35% 11.79% 11.46%
EPS 2 0.5300 0.5600 0.5200 0.4800 0.2100 0.2100
Free Cash Flow 1 31.02 11.58 8.476 60.76 54.26 -56.42
FCF margin 10.68% 3.66% 2.49% 17.37% 19.15% -19.29%
FCF Conversion (EBITDA) 38.12% 13.97% 11.19% 81.59% 166.61% -
FCF Conversion (Net income) 48.77% 17.39% 13.56% 106.26% 162.38% -
Dividend per Share - - - 0.1600 0.1000 0.1000
Announcement Date 12/29/20 12/29/20 4/24/22 4/24/22 4/27/23 4/22/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 94 102 134 553 451 331
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 31 11.6 8.48 60.8 54.3 -56.4
ROE (net income / shareholders' equity) 32.1% 26.6% 21% 10.6% 4.43% 4.23%
ROA (Net income/ Total Assets) 15.8% 14.9% 11.3% 6.25% 1.59% 1.79%
Assets 1 401.4 448 551.3 914.8 2,098 1,877
Book Value Per Share 2 1.920 2.260 2.700 4.690 4.740 4.850
Cash Flow per Share 2 0.7800 0.6200 0.9000 3.030 1.120 0.8200
Capex 1 1.35 12.8 46.1 3.09 5.54 38.6
Capex / Sales 0.47% 4.05% 13.52% 0.88% 1.96% 13.21%
Announcement Date 12/29/20 12/29/20 4/24/22 4/24/22 4/27/23 4/22/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 301111 Stock
  4. Financials Guangdong Lifestrong Pharmacy Co., Ltd.